Round dominated by corporate and global financial markets practices also sees three partners elevated in Singapore ...

Sullivan & Cromwell is acting for longtime client Merck in its $3.9bn acquisition of US biotech company SpringWorks Therapeutics, which is being repped by Goodwin Procter.